CT
Crispr Therapeutics AG
🇩🇪XFRA.1CGGermanyHealthcare
€45.27EURdown -0.12 (-0.26%)OpenEnd of day9:27 AM
Price€45.27-0.12 (-0.26%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- CH0334081137
- CUSIP
- Not reported
Company
- Employees
- 393
- Headquarters
- Zug, United States
- Website
- https://www.crisprtx.com
- CEO
- Dr. Samarth Kulkarni Ph.D.
Market
- Shares outstanding
- 96.7M
- Market cap
- €4.38B
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- €4.38B
- EPS LTM
- -$4.67
- P/E LTM
- -11.83
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $13.39M-64.15%down year on year
- Net income
- -$451.14M+3.56%up year on year
- Gross margin
- -1,534.39%-536.88%down year on year
- Free cash flow
- -$480.73M-47.66%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.